Our Pricing

Get £20 off Saxenda or Mounjaro with Code WEIGHTLOSSNEW

Published on: June 03, 2026

Looking for a saxenda mounjaro discount code uk pharmacy? Use code WEIGHTLOSSNEW at Cured Pharmacy to save on genuine UK-licensed weight loss injections. Our transparent pricing starts from £135.00 for Saxenda and £135.00 for Mounjaro, with free online consultation by UK prescribers and discreet next-day delivery across the UK.

How to Claim Your Saxenda or Mounjaro Discount Code

Redeeming your WEIGHTLOSSNEW discount code at Cured Pharmacy is straightforward. After completing your free online consultation with our UK-registered prescribers, you'll receive a clinical assessment within hours. If your prescriber approves Saxenda or Mounjaro for your weight management goals, simply enter code WEIGHTLOSSNEW at checkout to apply your discount.

Your discount applies to your first prescription order and can be combined with our lowest price guarantee. All orders are dispatched in 100% discreet packaging with tracked delivery, typically arriving the next working day across the UK. Our superintendent pharmacist Tarun Kumar (GPhC 2233073) ensures every prescription meets MHRA standards before dispatch.

Understanding Mounjaro: The Dual-Action Weight Loss Injection

Mounjaro is administered as a once-weekly subcutaneous injection using the convenient KwikPen device. Your UK prescriber will typically start you on a 2.5mg dose, gradually increasing over 16-20 weeks to your optimal maintenance dose (5mg, 7.5mg, 10mg, 12.5mg, or 15mg) based on your individual response and tolerability.

Common side effects include nausea, diarrhoea, and reduced appetite, which typically diminish as your body adjusts to each dose level [1]. Your prescriber will monitor your progress throughout treatment, adjusting your dose schedule if needed to minimise adverse effects whilst maximising weight loss outcomes.

How Tirzepatide Works Differently

Mounjaro contains tirzepatide, the first dual GIP/GLP-1 receptor agonist licensed by the MHRA for weight management in the UK [1]. Unlike single-pathway medications, tirzepatide activates both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors simultaneously, producing enhanced metabolic effects.

In the SURMOUNT-1 clinical trial, participants taking the highest maintenance dose achieved an average body weight reduction of 22.5% over 72 weeks — significantly exceeding results seen with semaglutide-based alternatives [1]. This dual mechanism helps regulate appetite, slow gastric emptying, and improve insulin sensitivity more effectively than single-receptor medications.

Saxenda: Daily Injection for Gradual Weight Management

Treatment begins at 0.6mg daily, increasing by 0.6mg each week until reaching the maintenance dose of 3mg daily. This gradual escalation helps minimise gastrointestinal side effects whilst allowing your body to adapt to the medication's appetite-suppressing effects. The pre-filled pen delivers up to 30 days of treatment at the maintenance dose.

Your UK prescriber will assess whether Saxenda suits your medical history, lifestyle, and weight management goals. Factors like your BMI, previous weight loss attempts, existing health conditions, and preference for daily versus weekly injections all influence which medication offers the best balance of efficacy and tolerability for you.

Liraglutide's Proven Track Record

Saxenda contains liraglutide 6mg/ml, a GLP-1 receptor agonist that has been available in the UK since 2015 for chronic weight management [2]. Unlike weekly injections, Saxenda is administered daily, giving you more frequent dosing control and the ability to adjust timing around your schedule.

The SCALE clinical programme demonstrated that patients using Saxenda alongside lifestyle modifications achieved an average weight loss of 8-9% of initial body weight over 56 weeks [2]. Whilst this is lower than newer dual-agonist medications, Saxenda remains an effective first-line option for many patients, particularly those who prefer daily dosing or have contraindications to other treatments.

Comparing Weight Loss Treatments: Which Injection Is Right for You?

Choosing between Saxenda, Mounjaro, and Wegovy depends on multiple clinical factors that your UK prescriber will evaluate during your consultation. Mounjaro's dual-receptor mechanism typically produces the greatest weight reduction in clinical trials, making it suitable for patients with higher BMIs or those who haven't responded adequately to single-pathway GLP-1 medications [1][3].

Wegovy (semaglutide) offers a middle ground, with once-weekly dosing and average weight reductions of 15-17% in the STEP clinical trials [3]. Its longer track record in the UK market means prescribers have extensive real-world experience managing side effects and optimising dosing schedules. Patients who experience significant nausea with Mounjaro sometimes tolerate Wegovy better due to its single-pathway mechanism.

Saxenda remains the most accessible option for many patients, particularly those new to injectable weight loss treatments or with mild-to-moderate obesity. The daily dosing schedule provides more flexibility to skip or delay doses if you experience side effects, and the lower starting price makes it an economical entry point whilst you assess your tolerance to GLP-1 medications [2].

Your prescriber will also consider contraindications: all three medications are unsuitable if you have a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2. Pregnancy, breastfeeding, and certain gastrointestinal conditions may also influence which treatment is prescribed.

Clinical Requirements and Online Consultation Process

NICE guidelines recommend prescription weight loss medications for adults with a BMI of 30 kg/m² or above, or 27 kg/m² with weight-related comorbidities such as type 2 diabetes, hypertension, or sleep apnoea [4]. Your prescriber will verify you meet these clinical criteria and that injectable treatment is appropriate given your overall health status.

Once approved, your prescription is sent electronically to our dispensing team. Our superintendent pharmacist Tarun Kumar conducts a final clinical check before your medication is prepared for dispatch. You'll receive tracking information and can contact our pharmacist team on (+44) 116 4646009 if you have questions about administration, storage, or side effects during treatment.

What to Expect During Your Assessment

All prescription weight loss medications at Cured Pharmacy require a clinical assessment by a UK-registered prescriber before dispensing. Our online consultation typically takes under three minutes and covers your medical history, current medications, weight loss goals, and any contraindications to GLP-1 or dual-agonist treatments.

You'll need to provide accurate information about your BMI, previous weight management attempts, any history of pancreatitis or thyroid conditions, and current medications that might interact with weight loss injections. Our prescribers assess each case individually — there's no automatic approval, and some patients may be advised to try alternative treatments or lifestyle modifications first.

Maximising Results: Lifestyle Modifications Alongside Medication

Common side effects like nausea and reduced appetite mean you may need to adjust your eating patterns. Smaller, more frequent meals often work better than three large meals daily. Avoid high-fat foods, which can worsen gastrointestinal symptoms, and stay well-hydrated to prevent constipation — a frequent complaint with GLP-1 medications.

Your prescriber may recommend working with a registered dietitian or weight management service to optimise your nutrition plan. Many patients find keeping a food diary helps identify patterns and ensures they're meeting nutritional needs despite reduced appetite. Remember that these medications are tools to support behaviour change, not replacements for sustainable lifestyle modifications that you'll maintain long-term.

Nutrition and Exercise Strategies

Injectable weight loss medications work most effectively when combined with sustainable dietary changes and increased physical activity. Clinical trials showing the impressive weight reductions with Mounjaro and Saxenda all included participants following structured lifestyle intervention programmes alongside medication [1][2].

Focus on a calorie deficit of 500-750 kcal per day through balanced nutrition rather than extreme restriction. The appetite suppression from GLP-1 medications makes this deficit feel more manageable, but adequate protein intake (1.2-1.6g per kg body weight) remains essential to preserve lean muscle mass during weight loss. Aim for 150 minutes of moderate-intensity exercise weekly, gradually increasing as your fitness improves.

Scientific References

1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
2. Pi-Sunyer, X., Astrup, A., Fujioka, K., et al. (2015). A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. New England Journal of Medicine, 373(1), 11–22. https://doi.org/10.1056/NEJMoa1411892 [accessed 13 August 2026]
3. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
4. National Institute for Health and Care Excellence. (2023). Obesity: identification, assessment and management (CG189). NICE. https://www.nice.org.uk/guidance/cg189 [accessed 13 August 2026]
5. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
6. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
7. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary, and weight loss outcomes depend on multiple factors including adherence to lifestyle modifications alongside medication.